Spinális izomatrófia (SMA): vizsgálatok itt: Kína
11 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Where
- Guangzhou, Shanghai, Zhengzhou
- Életkor
- 0 nap to 42 nap
- People
- 30 worldwide
- Run by
- Biogen
See details and how to joinNCT07221669 · EU 2025-524054-34-00 - No phaseTaking peopleEffects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
- Where
- Beijing
- Életkor
- 6 év to 12 év
- People
- 13
- Run by
- Peking University Third Hospital
See details and how to joinNCT07822711 - 1/2. fázisTaking peopleA Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
- Where
- Beijing, Hangzhou, Shanghai
- Életkor
- Up to 180 nap
- People
- 11
- Run by
- Lanyue Biotech (Hangzhou) Co., Ltd.
See details and how to joinNCT07554924 - 3. fázisTaking peopleA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
- Where
- Beijing
- Életkor
- 15 év to 60 év
- People
- 90 worldwide
- Run by
- Biogen
See details and how to joinNCT07444476 - No phaseCsak meghívásosGCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy
- Where
- Hangzhou
- Életkor
- 2 év to 12 év
- People
- 6
- Run by
- Genecombio Ltd.
See details and how to joinNCT06772402 - 1/2. fázisTaking peopleEvaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
- Where
- Beijing, Shenyang, Suzhou
- Életkor
- 0 hónap to 6 hónap
- People
- 18
- Run by
- GeneCradle Inc
See details and how to joinNCT05824169 - 1/2. fázisTaking peopleEvaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
- Where
- Beijing
- Életkor
- 2 év and over
- People
- 21
- Run by
- GeneCradle Inc
See details and how to joinNCT06421831 - 3. fázisTaking peopleSafety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
- Where
- Beijing, Shanghai, Shenzhen, Suzhou, Wuhan
- Életkor
- 2 év to 12 év
- People
- 50
- Run by
- GeneCradle Inc
See details and how to joinNCT06971094 - Korai 1. fázisCsak meghívásosClinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy
- Where
- Shanghai
- Életkor
- 1 nap to 2 év
- People
- 4
- Run by
- Guangzhou Jiayin Biotech Ltd
See details and how to joinNCT06888661 - No phaseCsak meghívásosA Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA
- Where
- Shanghai
- Életkor
- 1 hónap and over
- People
- 18
- Run by
- Guangzhou Jiayin Biotech Ltd
See details and how to joinNCT06588803 - No phaseTaking peopleA Registered Cohort Study on SMA
- Where
- Fuzhou
- Életkor
- 1 hét to 70 év
- People
- 2000
- Run by
- Wan-Jin Chen
See details and how to joinNCT04010604